Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
|
|
Audience:
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
educational grants from
Bristol Myers Squibb and Takeda Pharmaceuticals USA, Inc.
Description:
Inflammatory bowel disease (IBD) is a chronic, frequently
progressive condition that affects approximately 1.6 million people
in the United States. This lifelong, systemic autoimmune illness
often strikes patients at a young age and must be managed across a
lifetime. According to the Crohn’s and Colitis Foundation of
America, there are as many as 70,000 new cases diagnosed in a year.
The diagnosis of IBD is most commonly based on imaging to assess the
portions of the small bowel that are inaccessible to optical
endoscopic visualization, which may also include a combination of
endoscopy and histopathology. Imaging plays a critical role in the
initial diagnosis and ongoing evaluation of IBD patients. The
treatment goal for IBD is to reduce the inflammation, in hopes of
achieving reduced symptoms and possibly remission. Immediate goals
are to control the symptoms, induction of remission, and to help
improve a patient’s quality of life, while long-term goals include
maintenance of a corticosteroid-free clinical remission, mucosal
healing, endoscopic remission, prevention or cure of complications,
restoration, and maintenance of proper nutrition. The first step for
IBD treatment is aminosalicylates, which are useful for treating
flares of IBD and for maintaining remission. There is also the use
of antibiotics to treat bacterial infections that may result from
abscesses or fistulas. Corticosteroids can be used, as they are
rapid-acting anti-inflammatory agents, but they are indicated for
acute flares of disease only and have no role in the maintenance of
remission. Immunomodulators have a slower onset of action and work
to reduce patients’ overactive immune system but unlike
corticosteroids, they can be used as a long-term treatment. Now
treatment guidelines include the use of biologics, which are
proteins that stop certain molecules in the body from causing
inflammation in the GI tract. These are usually prescribed to those
living with moderate to severe cases of IBD who have not responded
to other types of treatment.
Upon completion of this
activity, participants will be able to:
-
Discuss recent guidelines on
diagnosis and management of inflammatory bowel disease(IBD)
-
Explore updated personalized
diagnostic and prognostic testing to determine appropriate
treatment strategies
-
Analyze the recent data for targeted
therapies, biologics, and small molecule treatments for IBD
based on their mechanism of action, indications, efficacy, and
safety
-
Explore the efficacy and safety data
for oral S1P receptor modulators in the treatment of IBD
-
Assess the short-term outcomes in
IBD based on clinical evidence and treatment strategy
-
Discuss managed care considerations,
including the role of a multidisciplinary team, that will help
decrease the clinical and economic burden and improve patient
outcomes
|
Faculty: |
Joseph Feuerstein, MD
Associate Clinical Chief
Gastroenterology Center for IBD
Associate Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center |
|
Disclosure:
|
(Relevant Financial Relationships with Ineligible
Companies in the Last 24 Months):
Dr. Feuerstein has no relevant financial relationship
with an ineligible company to disclose. |
|
Planning Committee: |
Bill
Williams, MD has no relevant financial relationships
with an ineligible company in the last 24 months to
disclose.
Jeremy Williams has no relevant financial relationships
with an ineligible company in the last 24 months to
disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial
relationships with an ineligible company in the last 24
months to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity. |
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
This activity is supported by educational grants from
Bristol Myers Squibb and Takeda Pharmaceuticals USA, Inc.
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
professional.
Click Here To Continue |